Mark Petrie is Professor of Cardiology in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, UK, and a Cardiologist at the Golden Jubilee National Hospital and Glasgow Royal Infirmary, Glasgow, UK. Professor Mark Petrie started his studies as an undergraduate in Edinburgh University before training in Cardiology in Glasgow. He worked as a heart failure and interventional cardiologist for many years before transferring to the University of Glasgow in 2016. Professor Petrie's research interests focus on diabetes and cardiovascular disease heart failure, structural intervention in heart failure, revascularization in heart failure, peripartum cardiomyopathy, microvascular disease in HFpEF, post-MI cardiac remodeling, iron in heart failure and cardio-oncology. Whilst Professor Petrie has many research interests, he also takes pleasure in mentoring the future high-caliber cardiologists and has supervised many outstanding individuals during their PhDs and MDs. Professor Petrie was an author of the 2011 European Society of Cardiology NSTEMI Guidelines and a reviewer of the 2016 ESC Heart Failure Guidelines. He was second author of the European Society of cardiology’s Position Statement on diabetes and heart failure. Mark is on the Steering Committee of many large trials and is National Leader for Dapa-HF and PARADISE-MI. he has been on the Clinical Events Committees of over 40 trials including EMPA-REG OUTCOMES, CARMELINA and CAROLINA. Throughout his career Professor Petrie has published around 180 original manuscripts including many in high impact journals such as New England Journal of Medicine, The Lancet, European Heart Journal, Journal of the American College of Cardiology and Circulation.